http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Adoption of a PDA-Based Home Hospice Care System for Cancer Patients :
HONG, HAE SOOK,KIM, IL KON,LEE, SUNG HEE,KIM, HWA SUN Ovid Technologies (Wolters Kluwer) - Lippincott Wi 2009 Computers, informatics, nursing Vol.27 No.6
<P>This study describes a systematic and efficient point-of-care home hospice information system, which can effectively manage patient information and can easily be incorporated into a home hospice service using wired and/or wireless communications and mobile computing technology. To help with the design of a portable home hospice information system, we analyzed the services provided by visiting nurses and the opinions of users, based on the 2005 Guidelines for Cancer Patient Management Program of the Ministry of Health and Welfare of Korea. We performed a service trial with three experienced visiting nurses. A visiting nurse can use a PDA, implementing the hospice information system, to accomplish tasks that range from registering a new patient to performing nursing services based on the patient's condition, as well as accessing guidelines and searching past information for better nursing performance. The system resulted in a saving of 8.5 minutes in recoding time. We expect the findings of this study to help field workers in community nursing care by reducing unnecessary paperwork and by enabling improvements in the quality of point-of-care services.</P>
Sohn, Dong-Seok,Lee, Jung-Kwang,An, Kyung-Mi,Shin, Hong-In Ovid Technologies (Wolters Kluwer) - Lippincott Wi 2009 Implant dentistry Vol.18 No.2
<P>PURPOSE: The aim of this article is to report the histomorphometric analysis and clinical study of mineralized cancellous bone allografts in maxillary sinus augmentation procedures in 4 cases. MATERIALS AND METHODS: Sinus bone augmentation, using a piezoelectric device and mineralized cancellous allografts, was performed in 3 patients. After an average of about 8 months of healing, a trephine core sample was gained from the lateral windows area for histomorphometric analysis. The mineralized cancellous allografts demonstrated normal healing of hard tissues. RESULTS: Upon reentry for dental implant placement or secondary surgery, the graft materials showed hard bony structures within the maxillary sinus. Histomorphometric analysis of the cores revealed an average vital new bone content of 17.88%. CONCLUSION: Mineralized cancellous allografts showed favorable bone regeneration histologically and was clinically useful in augmenting bone volume for implant placement in the sinus bone graft.</P>
Shin, Ho-Jin,Chung, Joo Seop,Choi, Young Jin,Cho, Goon Jae Ovid Technologies (Wolters Kluwer) - Lippincott Wi 2009 American journal of clinical oncology: cancer clin Vol.32 No.3
<P>OBJECTIVES: Priming with granulocyte macrophage colony-stimulating factor (GM-CSF) plus all-trans retinoic acid (ATRA) during induction chemotherapy may enhance response rates and survival in patients with acute myeloid leukemia (AML) due to the differentiation of human myeloblastic leukemia cells into granulocytes. METHODS: GM-CSF was administered to patients during induction chemotherapy and ATRA was ingested orally on days 1 to 14. Patients undergoing a regimen with GM-CSF and ATRA were evaluated as compared with a historical control group of subjects. RESULTS: For patients enrolled in this study, the complete remission plus complete remission with incomplete platelet recovery rate was 61.5% as compared with 41.4% for the historical control group of subjects. The relapse rate was 38.5% and 44.8% for the study and control group of subjects, respectively. Two-year probabilities were 45.5% (study group) and 47.4% (control group) for disease-free survival and 38.5% (study group) and 36.2% (control group) for overall survival. The most frequent side effects included fever, headache, and skin lesions with pruritus and dyspnea with pulmonary congestion, similar to ATRA syndrome. CONCLUSIONS: Priming with GM-CSF plus ATRA during anthracycline-based chemotherapy is feasible in terms of response rate, but the toxicity of the regimen is significant.</P>